ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,010.31
-0.02%
US Tech 100
16,870.00
-0.39%
Dow Jones
37,929.38
0.41%
Brent Oil
86.465
0.06%
Bitcoin
64,976.01
2.34%
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Angle Plc (AGL) Quote

Angle Plc

Angle Plc (AGL)

AGL Energy Limited
Autogrill SPA
Agilon Health inc
Agree Realty Corp
Aguila Copper Corp
12.00
0.25
( 2.13% )
Updated: 08:22:59
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
12.00
Bid
11.50
Ask
12.50
Volume
1,088,031
11.25 Day's Range 12.00
9.125 52 Week Range 37.50
Market Cap
31.27M
Previous Close
11.75
Open
11.75
Last Trade
400
@
11.822
(O)
Last Trade Time
08:41:48
Financial Volume
-
VWAP
-
Average Volume (3m)
1,349,214
Shares Outstanding
260,580,547
Dividend Yield
-
PE Ratio
-1.44
Earnings Per Share (EPS)
-0.08
Revenue
1.04M
Net Profit
-21.69M

About Angle Plc

Sector
Business Services, Nec
Industry
Business Consulting
Website
www.angleplc.com
Headquarters
Guildford, Gbr
Founded
2003
Angle Plc is listed in the Business Services sector of the London Stock Exchange with ticker AGL. The last closing price for Angle was 11.75p. Over the last year, Angle shares have traded in a share price range of 9.125p to 37.50p.

Angle currently has 260,580,547 shares outstanding. The market capitalization of Angle is £31.27 million. Angle has a price to earnings ratio (PE ratio) of -1.44.

AGL Latest News

More News

Angle PLC Parsortix HER2 assay showcased at AACR 2024

Angle PLC 08 April 2024   For immediate release 8 April 2024   ANGLE plc ("the Company")   PARSORTIX HER2 ASSAY SHOWCASED AT PRESTIGIOUS INTERNATIONAL CANCER CONFERENCE   CTC HER2 assay being...

April 08 2024
RNS Non-Regulatory

Angle PLC Parsortix at European breast cancer conference

Angle PLC 22 March 2024   For immediate release 22 March 2024   ANGLE plc ("the Company")   PARSORTIX SYSTEM AND ASSAYS BEING SHOWCASED AT A LEADING EUROPEAN BREAST CANCER CONFERENCE   ANGLE...

March 22 2024
RNS Non-Regulatory

IN BRIEF: Angle highlights supportive data for DNA analysis tool

y-based medical diagnostics provider - Announces publication of a peer-reviewed paper in a special issue of the journa ...

January 22 2024
Alliance News

Angle PLC Potential utility in precision oncology

Angle PLC 22 January 2024 For immediate release 22 January 2024 ANGLE plc ("the Company") REVIEW PAPER ON MOLECULAR ANALYSIS OF PARSORTIX CTC HARVEST HIGHLIGHTS POTENTIAL UTILITY IN...

January 22 2024
RNS Non-Regulatory

Angle PLC Standard form for notification of major holdings

Angle PLC 10 January 2024 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if...

January 10 2024
UK Regulatory

Angle shares soar following "breakthrough" cancer diagnostics results

Angle PLC on Thursday said that "breakthrough results" from its latest blood sample cancer trials would allow it to e ...

January 04 2024
Alliance News

Angle PLC Shares Rise on Cancer Patient Blood Sample Analysis

By Ian Walker Angle PLC shares rose as much as 41% in early trade after the company said that DNA molecular analysis from cancer patient blood samples provides insight into the progression and...

January 04 2024
Dow Jones News

Angle PLC Breakthrough clinical results

Angle PLC 04 January 2024 For immediate release 4 January 2024 ANGLE plc ("the Company") BREAKTHROUGH CLINICAL RESULTS PROVIDE A UNIQUE INSIGHT INTO THE PROGRESSION OF EACH...

January 04 2024
UK Regulatory

IN BRIEF: Angle teams with Japan's Eisai in breast cancer drug trial

y, England-based medical diagnostics - Signs contract with Eisai Inc, part of Tokyo-based pharmaceutical firm Eisai Co ...

January 02 2024
Alliance News

Angle PLC Contract announcement with Eisai Inc.

Angle PLC 02 January 2024 For immediate release 2 January 2024 ANGLE plc ("the Company") CONTRACT ANNOUNCEMENT WITH LARGE PHARMA COMPANY, EISAI INC. Pilot study for ANGLE's...

January 02 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.75-12.727272727313.7513.7511.25114480612.28450985DE
4-1.25-9.4339622641513.2516.7511.25128391713.18884288DE
12-5.25-30.434782608717.252011.25134921415.61933712DE
260.252.1276595744711.7537.59.125276337118.82214671DE
52-5.75-32.394366197217.7537.59.125193779818.25019972DE
156-86-87.755102040898163.59.125136486245.85753266DE
260-62.5-83.892617449774.5163.59.125104641149.19947847DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RWODRedwoods Acquisition Corporation
$ 12.87
(60.94%)
3.19M
ZCMDZhongchao Inc
$ 2.3023
(58.78%)
20.48M
AGBAAGBA Group Holding Ltd
$ 1.4699
(42.71%)
37.14M
EGOXNext e GO NV
$ 0.0453
(25.83%)
39.43M
PRTGPortage Biotech Inc
$ 0.29375
(22.40%)
68.37k
SBFMSunshine Biopharma Inc
$ 2.3499
(-29.22%)
3.9M
GSUNGolden Sun Health Technology Group Ltd
$ 3.86
(-21.24%)
5.26k
DWSNDawson Geophysical Company
$ 1.7544
(-19.89%)
13.63k
BGLCBioNexus Gene Lab Corporation
$ 0.69
(-18.69%)
162.52k
TIRXTian Ruixiang Holdings Ltd
$ 0.6511
(-18.61%)
566.68k
EGOXNext e GO NV
$ 0.0453
(25.83%)
39.43M
AGBAAGBA Group Holding Ltd
$ 1.4699
(42.71%)
37.14M
ZCMDZhongchao Inc
$ 2.3023
(58.78%)
20.49M
SQQQProShares UltraPro Short QQQ
$ 12.2407
(1.41%)
17.35M
SINTSiNtx Technologies Inc
$ 0.0395
(-1.25%)
16.55M

Discussion

View Full Feed
newman2021 newman2021 3 minutes ago
You are short sighted, imo; An army of MHRA officers/regulators are working hard to get these kind of life saving drugs to the needy patients day and night, as they are honest people duty minded souls... not the penny collecting low shorts in a message board.
NWBO
money-maker money-maker 4 minutes ago
Exactly. It is just a matter of time!
SPZI
BIOChecker4 BIOChecker4 4 minutes ago
Theres a huge disconnect between what Missling says in his presentation and what the market perceives. We’ll learn the truth eventually, one way or the other. I’ll continue to hold my remaining shares but I’m not going to bottom fish. If Missling actually gets EMA approval, I’ll gladly pay $20 for a
AVXL
mick mick 4 minutes ago
cantlay looks strong for change
koolmc koolmc 4 minutes ago
ronn .0008 prints
Backstabbed Backstabbed 4 minutes ago
we'll just add more. thanks
ILST
koolmc koolmc 4 minutes ago
drnk .0011 up
Stockman1010101 Stockman1010101 4 minutes ago
Its like saying to your family, hey why are you spending money on all this food, you dont need to eat, but I see you are surviving and in the case of the kids, actually growing.
Agree you need money to run a business and to live as a person in order to buy food. Neither of which this company
AITX
Ronnie Replay Ronnie Replay 4 minutes ago
Uber. What stocks do you like?
SPZI
Hawk05 Hawk05 4 minutes ago
Rumor has it that your real identity is Dr. Rachel Levine!

LMAO
BIEL
TrendTrade2016 TrendTrade2016 4 minutes ago
HUMA HERE COMES FOUR...BRAKING DOWN THE BATHROOM DOOR!!!
HUMA
tw0122 tw0122 4 minutes ago
THAR .36 bottom should be in .40 next target
Hugie Hugie 4 minutes ago
Wena but not for Leas but Rwod.
LEAS
sumbuysumsell sumbuysumsell 4 minutes ago
And down the share price goes. Swirling down the drain.
I dream of a PR with the headline "Anavex Announces Management Change". It includes many attaboy pats on the back and some inspirational quotes on how far Anavex has come. The time for detailed low budget financial management is over. H
AVXL
SonicTheHedgeFun SonicTheHedgeFun 5 minutes ago
Lol paid bashers coming out to try and take your shares XD
JAGX
9HikeDiscGolf 9HikeDiscGolf 5 minutes ago
The lowest we ever went through the lowest price was .20. That not even close yet. Still 100% above from lowest low.
TELL
getmoreshares getmoreshares 5 minutes ago
shares hidden at .1885- added today
BLFR
bas2020 bas2020 5 minutes ago
Let's see how much of the collusive short positions start covering today. Looks like a big buying/reloading opportunity with this collusive HF manipulative take down.
AVXL
drugmanrx drugmanrx 5 minutes ago
I believe that is incorrect ". But unless it produces income, there will be no pps increase."

Notice the revenue and the stock price
https://www.otcmarkets.com/filing/html?id=17031890&guid=m4Q-ka3VoTeHJth
SHMN
ChannelTrader ChannelTrader 5 minutes ago
Israel Launches Attack On Iran; Explosions Heard In Areas With Nuclear Sites

https://truthpress.com/news/israel-launches-attack-on-iran-explosions-heard-in-areas-with-nuclear-sites/

Israel launched an attack against the Islamic Republic of Iran during the early morning
Eddo1976 Eddo1976 5 minutes ago
The new symbol is supposed to be WENA, which isn’t trading yet.
LEAS
MightyX MightyX 5 minutes ago
Retail has-had plenty-of-opportunity to make company appear failing..this isn’t one of them.
TPTW
stockinspector stockinspector 5 minutes ago
Depends, you may need to pick up a full package. bid is showing 24m that can't buy a thrill. Now it will cost an extra 30% to play
WDLF
StonkMaster StonkMaster 5 minutes ago
We can agree to disagree here Newman. Not saying you're wrong, just saying we don't have anyway to confirm this.

AFAIK, there is a difference between a receipt of submission and validation of the application (which the MHRA themselves told me usually takes up to 14 days).
NWBO

Your Recent History

LSE
AGL
Angle
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved